Clinical Trial Update: Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating vitamin D repletion in patients with Parkinson's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Emory University | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED